- Home
- Labeler Index
- Abbvie Srl
- 62526-2041
- NDC Crossover: 62526-2041 Risankizumab-rzaa
NDC Crossover 62526-2041 Risankizumab-rzaa
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching
Explore similar products and medications to NDC 62526-2041 Risankizumab-rzaa drug for further processing with other products crossover matching the same product name (Risankizumab-rzaa) or generic name (Risankizumab-rzaa), and the same administration route () or dosage form (kit). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0074-1065 | Skyrizi | Risankizumab-rzaa | Kit | Intravenous | Abbvie Inc. | Human Prescription Drug |
0074-1070 | Skyrizi | Risankizumab-rzaa | Kit | Intravenous | Abbvie Inc. | Human Prescription Drug |
0074-7034 | Skyrizi | Risankizumab-rzaa | Kit | Abbvie Inc. | Human Prescription Drug | |
0074-7036 | Skyrizi | Risankizumab-rzaa | Kit | Abbvie Inc. | Human Prescription Drug | |
0074-7040 | Skyrizi | Risankizumab-rzaa | Kit | Abbvie Inc. | Human Prescription Drug | |
0074-7042 | Skyrizi | Risankizumab-rzaa | Kit | Abbvie Inc. | Human Prescription Drug |